Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,051 | 271 | 93.2% |
| Travel and Lodging | $221.13 | 1 | 5.1% |
| Education | $76.56 | 4 | 1.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,242 | 108 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $449.38 | 28 | $0 (2024) |
| Covidien LP | $381.38 | 4 | $0 (2018) |
| Valeant Pharmaceuticals North America LLC | $265.40 | 17 | $0 (2017) |
| Takeda Pharmaceuticals U.S.A., Inc. | $264.41 | 14 | $0 (2024) |
| Synergy Pharmaceuticals Inc | $163.18 | 10 | $0 (2018) |
| Intercept Pharmaceuticals, Inc. | $162.73 | 10 | $0 (2020) |
| Janssen Biotech, Inc. | $142.48 | 9 | $0 (2024) |
| Shionogi Inc | $132.89 | 8 | $0 (2019) |
| IRONWOOD PHARMACEUTICALS, INC | $126.33 | 8 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $607.75 | 32 | Takeda Pharmaceuticals U.S.A., Inc. ($135.29) |
| 2023 | $285.33 | 14 | ABBVIE INC. ($90.45) |
| 2020 | $249.80 | 14 | AMAG Pharmaceuticals, Inc. ($56.47) |
| 2019 | $862.63 | 65 | AbbVie, Inc. ($386.62) |
| 2018 | $1,293 | 78 | AbbVie, Inc. ($315.65) |
| 2017 | $1,050 | 73 | AbbVie, Inc. ($352.03) |
All Payment Transactions
276 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $17.87 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/12/2024 | Takeda Pharmaceuticals U.S.A., Inc. | EOHILIA (Drug) | Food and Beverage | In-kind items and services | $23.92 | General |
| Category: INTERNAL MEDICINE | ||||||
| 12/05/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $18.09 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/04/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.82 | General |
| Category: Gastroenterology | ||||||
| 11/21/2024 | Takeda Pharmaceuticals U.S.A., Inc. | EOHILIA (Drug) | Food and Beverage | In-kind items and services | $19.95 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/19/2024 | Merck Sharp & Dohme LLC | DIFICID (Drug), ZERBAXA | Food and Beverage | In-kind items and services | $13.90 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 11/13/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $16.25 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/12/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $19.14 | General |
| Category: THERAPY FOR CSID | ||||||
| 11/07/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $19.41 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/22/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $14.87 | General |
| Category: GI | ||||||
| 10/16/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $17.52 | General |
| Category: Immunology | ||||||
| 09/19/2024 | Takeda Pharmaceuticals U.S.A., Inc. | EOHILIA (Drug) | Food and Beverage | In-kind items and services | $23.63 | General |
| Category: INTERNAL MEDICINE | ||||||
| 09/12/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $24.52 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 09/09/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $20.99 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/21/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $16.54 | General |
| Category: Gastroenterology | ||||||
| 08/15/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $26.64 | General |
| Category: Immunology | ||||||
| 08/08/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $15.05 | General |
| Category: GI | ||||||
| 08/01/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $21.53 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/17/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $20.65 | General |
| Category: Gastroenterology | ||||||
| 07/11/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $19.09 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 06/26/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $19.25 | General |
| Category: Immunology | ||||||
| 05/28/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $21.03 | General |
| Category: Immunology | ||||||
| 05/14/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $20.54 | General |
| Category: GASTROENTEROLOGY | ||||||
| 04/30/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $11.31 | General |
| Category: INTERNAL MEDICINE | ||||||
| 04/24/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $18.73 | General |
| Category: Gastroenterology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 288 | 299 | $241,112 | $25,914 |
| 2022 | 6 | 330 | 368 | $303,371 | $32,433 |
| 2021 | 9 | 345 | 387 | $323,494 | $35,899 |
| 2020 | 8 | 300 | 323 | $265,150 | $26,278 |
All Medicare Procedures & Services
31 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 42 | 42 | $66,822 | $8,103 | 12.1% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 71 | 71 | $81,863 | $5,123 | 6.3% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 49 | 49 | $65,709 | $3,881 | 5.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 45 | 52 | $5,075 | $3,843 | 75.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 30 | 34 | $6,328 | $2,128 | 33.6% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 15 | 15 | $11,895 | $1,156 | 9.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 18 | 18 | $1,215 | $851.53 | 70.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 18 | 18 | $2,205 | $827.40 | 37.5% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 43 | 44 | $70,004 | $8,034 | 11.5% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 75 | 75 | $100,575 | $7,077 | 7.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 59 | 73 | $14,308 | $6,108 | 42.7% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 82 | 84 | $96,852 | $5,655 | 5.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 58 | 78 | $10,530 | $4,498 | 42.7% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 13 | 14 | $11,102 | $1,060 | 9.6% |
| 45385 | Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare | Facility | 2021 | 45 | 48 | $76,368 | $8,745 | 11.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 68 | 95 | $16,625 | $8,520 | 51.2% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 81 | 84 | $96,852 | $6,464 | 6.7% |
| 45380 | Biopsy of the large bowel using an endoscope (colonoscopy) | Facility | 2021 | 66 | 70 | $93,870 | $5,363 | 5.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 36 | 39 | $4,680 | $2,607 | 55.7% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 16 | 16 | $4,400 | $1,733 | 39.4% |
| 43249 | Balloon dilation of esophagus, stomach and upper small bowel using a flexible endoscope | Facility | 2021 | 11 | 12 | $17,256 | $1,067 | 6.2% |
| 43235 | Diagnostic examination of esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 11 | 12 | $9,516 | $889.70 | 9.3% |
| 91010 | Measurement of esophageal swallowing movement | Office | 2021 | 11 | 11 | $3,927 | $510.80 | 13.0% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2020 | 90 | 97 | $111,841 | $7,279 | 6.5% |
| 45380 | Biopsy of large bowel using an endoscope | Facility | 2020 | 60 | 60 | $80,460 | $6,049 | 7.5% |
About Dr. Reshi Kanuru, M.D
Dr. Reshi Kanuru, M.D is a Gastroenterology healthcare provider based in Fort Wayne, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/06/2010. The National Provider Identifier (NPI) number assigned to this provider is 1598080236.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Reshi Kanuru, M.D has received a total of $4,349 in payments from pharmaceutical and medical device companies, with $607.75 received in 2024. These payments were reported across 276 transactions from 33 companies. The most common payment nature is "Food and Beverage" ($4,051).
As a Medicare-enrolled provider, Kanuru has provided services to 1,263 Medicare beneficiaries, totaling 1,377 services with total Medicare billing of $120,524. Data is available for 4 years (2020–2023), covering 31 distinct procedure/service records.
Practice Information
- Specialty Gastroenterology
- Location Fort Wayne, IN
- Active Since 04/06/2010
- Last Updated 10/08/2022
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1598080236
Products in Payments
- Humira (Biological) $795.67
- XIFAXAN (Drug) $489.09
- Barrx (Device) $371.89
- Creon (Drug) $184.38
- Trulance (Drug) $163.18
- LINZESS (Drug) $146.55
- XIFAXANIBSD (Drug) $126.65
- STELARA (Biological) $124.96
- Mulpleta (Drug) $122.35
- Entyvio (Biological) $109.23
- LINX Reflux Management System (Device) $103.07
- Linzess (Drug) $101.13
- OCALIVA (Drug) $99.05
- FERAHEME (Drug) $76.56
- Cimzia (Drug) $72.10
- ENTYVIO (Biological) $70.98
- EOHILIA (Drug) $67.50
- INJECTAFER (Drug) $64.55
- OCA (Drug) $63.68
- IBSRELA (Drug) $59.03
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Fort Wayne
Dr. Efesomwan Aisien, M.d, M.D
Gastroenterology — Payments: $89,557
Dr. Abdo Saad, Md, MD
Gastroenterology — Payments: $59,492
Melissa Garrett, Md, MD
Gastroenterology — Payments: $59,090
Dr. Mariajose Rojas De Leon, Md, MD
Gastroenterology — Payments: $39,782
Dr. Kirsten Weiser, M.d, M.D
Gastroenterology — Payments: $20,935
Dr. David Gutman, Md, Facg, MD, FACG
Gastroenterology — Payments: $13,732